The Molecular Basis of Antithrombin Deficiency in Belgian and Dutch Families

Summary

The molecular basis of hereditary antithrombin (AT) deficiency has been investigated in ten Belgian and three Dutch unrelated kindreds. Eleven of these families had a quantitative or type I AT deficiency, with a history of major venous thromboembolic events in different affected members. In the other two families a qualitative or type II AT deficiency was occasionally diagnosed.

DNA studies of the AT gene were performed, using polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis, followed by direct sequencing of the seven exons and intronexon junction regions. Six novel point mutations were identified: four missense, one nonsense mutation and a single nucleotide deletion near the reactive site, causing a frameshift with premature translation termination. In two kindreds the underlying genetic defect was caused by a whole gene deletion, known as a rare cause of AT deficiency. In these cases, Southern blot and polymorphism analysis of different parts of the AT gene proved useful for diagnosis. In another kindred a partial gene deletion spanning 698 basepairs could precisely be determined to a part of intron 3B and exon 4. In two type I and in both type II AT deficient families a previously reported mutation was identified. In all cases, the affected individuals were heterozygous for the genetic defect.

• References

• 1 Egeberg O. Inherited antithrombin III deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-30.
• 2 Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Cooper DN, Blajchman M, Perry D, Emmerich J, Aiach M. Antithrombin III mutation database: first update. Thromb Haemost 1993; 70: 361-9.
• 3 Bock SC, Harris JF, Balazs I, Trent JM. Assignment of the human anti-thrombin III structural gene to chromosome 1q23-25. Cytogenet Cell Genet 1985; 39: 67-9.
• 4 Bock SC, Marrinan JA, Radziejewska E. Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site. Biochemistry 1988; 27: 6171-8.
• 5 Olds RJ, Lane DA, Chowdhury V, De Stefano V, Leone G, Thein SL. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. Biochemistry 1993; 32: 4216-24.
• 6 Lane DA, Ireland H, Olds RJ, Thein SL, Perry DJ, Aiach M. Antithrombin III: a database of mutations. Thromb Haemost 1991; 66: 657-61.
• 7 Lane DA, Bayston T, Olds RJ, Fitches AC, Cooper DN, Millar DS, Joch-mans K, Perry DJ, Okajima K, Thein SL, Emmerich J. Antithrombin mutation database: 2nd (1997) update. Thromb Haemost 1997; 77: 197-211.
• 8 Sas G, Pepper DS, Cash JD. Investigations on antithrombin III in normal plasma and serum. Br J Haematol 1975; 30: 265-72.
• 9 Jochmans K, Lissens W, Vervoort R, Peeters S, De Waele M, Liebaers I. Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood 1994; 83: 146-51.
• 10 Jochmans K, Lissens W, Yin T, Michiels JJ, van der Luit L, Peerlinck K, De Waele M, Liebaers I. Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutation. Blood 1994; 84: 3742-8.
• 11 Olds RJ, Lane DA, Chowdhury V, Sas G, Pabinger I, Auberger K, Thein SL. (ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations. Hum Mut 1994; 4: 31-41.
• 12 Hirsh J, Piovella F, Pini M. Congenital antithrombin III deficiency. Incidence and clinical features. Am J Med 1989; 87 suppl 3B 34S-8S.
• 13 Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: part 2. Thromb Haemost 1996; 76: 824-34.
• 14 van Boven HH, Vandenbroucke JP, Westendorp RG, Rosendaal FR. Mortality and causes of death in inherited antithrombin deficiency. Thromb Haemost 1997; 77: 452-5.
• 15 van Boven HH, Lane DA. Antithrombin and its inherited deficiency states. Semin Hematol 1997; 34: 188-204.
• 16 van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996; 75: 417-21.
• 17 Perry DJ. Antithrombin and its inherited deficiencies. Blood Rev 1994; 8: 37-55.
• 18 Huber R, Carrell RW. Implications of the three-dimensional structure of alpha-1 antitrypsin for structure and function of serpins. Biochemistry 1989; 28: 8951-66.
• 19 Carrell RW, Stein PE, Fermi G, Wardell MR. Biological implications of a 3A structure of dimeric antithrombin. Structure 1994; 2: 257-70.
• 20 Stein PE, Carrell RW. What do dysfunctional serpins tell us about molecular mobility and disease?. Nat Struct Biol 1995; 2: 96-113.
• 21 Perry DJ, Carrell RW. Molecular genetics of human antithrombin deficiency. Hum Mut 1996; 7: 7-22.
• 22 Davis AE, Kulwant A, Parad RB, Stecklein P, Eldering E, Hack CE, Kramer J, Strunk RC, Bissler J, Rosen FS. C1 Inhibitor hinge region mutations produce dysfunction by different mechanisms. Nature genet 1992; 1: 354-8.
• 23 White D, Abraham G, Carter C, Kakkar VV, Cooper DN. A novel missense mutation in the antithrombin III gene (Ala387 → Val) causing recurrent venous thrombosis. Human Genetics 1993; 90: 472-3.
• 24 von Heijne G. Patterns of amino acids near signal-sequence cleavage sites. Eur J Biochem 1983; 133: 17-21.
• 25 Daly M, Bruce D, Perry DJ, Price J, Harper PL, O’Meara A, Carrell RW. Antithrombin Dublin (-3 Val → Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site. FEBS Lett 1990; 273: 87-90.
• 26 Saleun S, De Moerloose P, Bura A, Aiach M, Emmerich J. A novel nonsense mutation in the antithrombin III gene (Cys-4 → stop) causing recurrent venous thrombosis. Blood Coag Fibrinolysis 1996; 7: 578-9.
• 27 van Boven HH, Olds RJ, Thein SL, Reitsma PH, Lane DA, Briet E, Vandenbroucke JP, Rosendaal FR. Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families. Blood 1994; 84: 4209-13.
• 28 Chowdhury V, Olds RJ, Lane DA, Conard J, Pabinger I, Ryan K, Bauer KA, Bhavnani M, Abildgaard U, Finazzi G, Castaman G, Mannucci PM, Thein SL. Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening. Br J Haematol 1993; 84: 656-61.